BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12941430)

  • 1. The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors.
    Seifert R; Wenzel-Seifert K
    Life Sci; 2003 Sep; 73(18):2263-80. PubMed ID: 12941430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High constitutive activity of the human formyl peptide receptor.
    Wenzel-Seifert K; Hurt CM; Seifert R
    J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.
    Wenzel-Seifert K; Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):509-15. PubMed ID: 12679864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state.
    Seifert R; Wenzel-Seifert K
    Recept Channels; 2001; 7(5):357-69. PubMed ID: 11697079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor.
    Wenzel-Seifert K; Seifert R
    Biochem Biophys Res Commun; 2003 Feb; 301(3):693-8. PubMed ID: 12565836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.
    Seifert R; Wenzel-Seifert K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):381-416. PubMed ID: 12382069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
    Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
    J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of F110 and C126 of the formyl peptide receptor interfere with G-protein coupling and chemotaxis.
    Jones BE; Miettinen HM; Jesaitis AJ; Mills JS
    J Periodontol; 2003 Apr; 74(4):475-84. PubMed ID: 12747452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of putative sites of interaction between the human formyl peptide receptor and G protein.
    Miettinen HM; Gripentrog JM; Mason MM; Jesaitis AJ
    J Biol Chem; 1999 Sep; 274(39):27934-42. PubMed ID: 10488141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
    Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
    J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
    Graham TE; Prossnitz ER; Dorin RI
    J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
    Bennett TA; Maestas DC; Prossnitz ER
    J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins.
    Key TA; Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49204-12. PubMed ID: 11598142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive contact between Gi2 and N-formyl peptide receptor of human neutrophils: mapping of binding sites using receptor-mimetic peptides.
    Bommakanti RK; Dratz EA; Siemsen DW; Jesaitis AJ
    Biochemistry; 1995 May; 34(20):6720-8. PubMed ID: 7756303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding.
    Bennett TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2001 Dec; 276(52):49195-203. PubMed ID: 11602585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity.
    Key TA; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    J Biol Chem; 2003 Feb; 278(6):4041-7. PubMed ID: 12424254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
    Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
    Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor.
    Murphy PM; McDermott D
    J Biol Chem; 1991 Jul; 266(19):12560-7. PubMed ID: 1712023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
    Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
    J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.